Mereo BioPharma Group plcMREO
Price (close)
$0.34
Market cap
$271.2M
P/E
—
Revenue (TTM)
$500,000
Net income
-$28.1M
Dividend yield
—
1-year total return
-80.9%
Net margin
—
Revenue growth
—
Debt / equity
—
What Mereo BioPharma Group plc does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $10.0M | $0 | $500,000 |
| Net income | — | — | -$42.2M | -$29.5M | -$43.3M | -$41.9M |
| Free cash flow | — | — | -$48.8M | -$21.1M | -$32.8M | -$31.0M |
More on MREO.
- Mereo BioPharma Group plc summary
- Mereo BioPharma Group plc financial statements
- Mereo BioPharma Group plc key metrics
- Mereo BioPharma Group plc health scores and style box
- Mereo BioPharma Group plc earnings
- Mereo BioPharma Group plc dividends
- Mereo BioPharma Group plc valuation
- Mereo BioPharma Group plc ownership and insiders
- Mereo BioPharma Group plc peers
Figures from Mereo BioPharma Group plc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.